Onyx Biotec Limited (NSE:ONYX)

Onyx Biotec Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	10.68	49.54	36.35	18.45	33.53
Depreciation & Amortization	30.73	30.47	18.67	14.91	14.48
Loss (Gain) From Sale of Assets	-	-9.54	-	-	-
Other Operating Activities	15.87	40.34	30.44	13.04	11.38
Change in Accounts Receivable	-85.51	-48.6	-102.97	33.42	-60
Change in Inventory	-1.92	-69.97	-27.74	-32.76	2.99
Change in Accounts Payable	4.78	29.46	68.63	26.06	30.08
Change in Other Net Operating Assets	-12.61	-7.54	-8.21	-10.75	-27.6
Operating Cash Flow	-37.97	14.17	15.16	62.36	4.85
Operating Cash Flow Growth	-	-6.54%	-75.69%	1184.71%	-
Capital Expenditures	-11.84	-10.55	-32.23	-227.37	-57.86
Sale of Property, Plant & Equipment	1.88	15.39	-	-	-
Other Investing Activities	1.44	1.73	0.75	0.65	0.1
Investing Cash Flow	-8.52	6.56	-31.48	-226.72	-57.76
Short-Term Debt Issued	-	-	-	75.99	24.79
Long-Term Debt Issued	-	-	55.75	93.86	32.34
Total Debt Issued	-4.47	-	55.75	169.84	57.13
Short-Term Debt Repaid	-	-14.88	-40.23	-	-
Long-Term Debt Repaid	-	-168.34	-	-	-
Total Debt Repaid	-139.89	-183.23	-40.23	-	-
Net Debt Issued (Repaid)	-144.37	-183.23	15.52	169.84	57.13
Issuance of Common Stock	253.8	253.8	36.46	-	-
Other Financing Activities	-6.24	-19.86	-21.07	-5.55	-5.15
Financing Cash Flow	103.2	50.72	30.91	164.3	51.98
Miscellaneous Cash Flow Adjustments	-	-	-	-42.83	0
Net Cash Flow	56.71	71.45	14.59	-42.9	-0.93
Free Cash Flow	-49.81	3.62	-17.07	-165.01	-53
Free Cash Flow Margin	-7.50%	0.58%	-3.17%	-41.78%	-11.82%
Free Cash Flow Per Share	-3.02	0.24	-1.43	-13.98	-4.49
Cash Interest Paid	6.24	19.86	21.07	5.55	5.15
Levered Free Cash Flow	-59.31	-24.9	-57.82	-172.52	-
Unlevered Free Cash Flow	-51.93	-12.44	-44.66	-168.99	-
Change in Working Capital	-95.26	-96.64	-70.29	15.97	-54.53

Source: S&P Global Market Intelligence. Standard template. Financial Sources.